StreetAlpha
Braveheart Bio, Inc. · SEC Form 4

BRVE Insider Trading

From SEC Form 410 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Braveheart Bio, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are buying over the last 12 months: $159M bought and $0 sold.

← BRVE stock page

Insiders are buying
Bought, 12 months$159M10 buys · 10 insiders
Sold, 12 months$00 sales · 0 insiders
Net+$159Mbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFebMarAprMayJunJul2026-08: bought $159MAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when BRVE insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an BRVE officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

BRVE cluster buys

All BRVE cluster buys →
  • 10 insiders bought $159MTrades Aug 7, 2026 to Aug 7, 2026 · public Aug 7, 2026

A cluster buy is two or more insiders buying on the open market within 30 days of each other.

Every BRVE insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Aug 7, 2026Orbimed Advisors LLCDirectorBuy1,940,000$18.00$34.9M273,333Aug 11Form 4
Aug 7, 2026Erez ChimovitsDirectorBuy1,940,000$18.00$34.9M273,333Aug 11Form 4
Aug 7, 2026AH Bio Fund IV, L.P.10% ownerBuy1,100,000$18.00$19.8M10,232,420Aug 11Form 4
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.10% ownerBuy3,600,000$18.00$64.8M10,185,478Aug 7Form 4
Aug 7, 2026David Charles LubnerDirectorBuy55,555$18.00$1000K55,555Aug 7Form 4
Aug 7, 2026Travis MurdochCEO and PresidentBuy83,333$18.00$1.5M2,940,670Aug 7Form 4
Aug 7, 2026Michele A. AndersonChief Development OfficerBuy1,111$18.00$20K332,161Aug 7Form 4
Aug 7, 2026David I MalekDirectorBuy4,166$18.00$75K533,845Aug 7Form 4
Aug 7, 2026Christopher ViehbacherDirectorBuy83,333$18.00$1.5M609,519Aug 7Form 4
Aug 7, 2026James Paul RickeyCFOBuy27,777$18.00$500K520,927Aug 7Form 4

BRVE insider trading FAQ

Are BRVE insiders buying or selling?

Insiders are buying over the last 12 months. 10 insiders bought $159M of BRVE on the open market in 10 trades, and 0 sold $0 in 0 trades.

When did an BRVE insider last buy shares?

Orbimed Advisors LLC (Director) bought 1,940,000 shares for $34.9M on Aug 7, 2026, reported on Aug 11, 2026.

When did an BRVE insider last sell shares?

There has been no open market insider sale of BRVE in the last two years.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice